Serum inhibin and disease status in women with ovarian granulosa cell tumors

被引:55
作者
Boggess, JF [1 ]
Soules, MR [1 ]
Goff, BA [1 ]
Greer, BE [1 ]
Cain, JM [1 ]
Tamimi, HK [1 ]
机构
[1] UNIV WASHINGTON,DIV REPROD ENDOCRINOL,SEATTLE,WA 98195
关键词
BLEOMYCIN COMBINATION CHEMOTHERAPY; HUMAN MENSTRUAL-CYCLE; VINBLASTINE; MARKER;
D O I
10.1006/gyno.1996.4520
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To determine if immunoreactive inhibin assayed in serum from women with granulosa cell tumors correlated with tumor burden, reflected response to treatment, or predicted recurrent disease. Study design. Serum samples were collected following bilateral oophorectomy (BSO) with or without other indicated surgery in 15 patients with granulosa cell tumors. Inhibin radioimmunoassay (RIA-Inh) was performed on all samples and results were correlated with tumor burden, disease status, and treatment response. Results. Fifteen patients had serum assayed for inhibin with levels ranging from 0 to 7470 U/liter. In 4 patients with measurable recurrent disease, inhibin levels correlated directly with tumor burden (r(2) = 0.96). Four patients had serum drawn during clinical remission and in all 4 patients elevated inhibin levels predated recurrence by a median interval of 11.5 months (range 7-20). The remaining 7 were treated for primary disease and were in clinical remission with a median follow-up of 33 months (range 9-53). Four of these 7 patients were surgically staged: 2 were FIGO Stage I and inhibin levels fell to O U/liter; 2 patients had metastatic disease (Stage Ilc and ma) and their inhibin levels were found to be elevated following complete resection. The remaining 3 were not surgically staged, and all had elevated inhibin levels while in clinical remission, suggesting occult disease. Of the 15 total patients, 1 who was treated with chemotherapy for recurrent disease was followed with serial inhibin levels. She showed a complete response to therapy with inhibin levels falling from 975 to O U/liter with 15 months follow-up. Conclusions. Serum inhibin levels reflect tumor burden and may be valuable in assessing response to chemotherapy or predicting recurrent disease in women with granulosa cell tumors who have had BSO. Serum inhibin level evaluation should be incorporated into large-group trials of therapy for granulosa cell tumors. (C) 1997 Academic Press
引用
收藏
页码:64 / 69
页数:6
相关论文
共 25 条
  • [1] PROGNOSTIC FACTORS IN GRANULOSA-CELL TUMORS
    BJORKHOLM, E
    SILFVERSWARD, C
    [J]. GYNECOLOGIC ONCOLOGY, 1981, 11 (03) : 261 - 274
  • [2] CISPLATIN, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN METASTATIC GRANULOSA-CELL TUMOR OF THE OVARY
    COLOMBO, N
    SESSA, C
    LANDONI, F
    SARTORI, E
    PECORELLI, S
    MANGIONI, C
    [J]. OBSTETRICS AND GYNECOLOGY, 1986, 67 (02) : 265 - 268
  • [3] INHIBIN AS A MARKER FOR OVARIAN-CANCER
    COOKE, I
    OBRIEN, M
    CHARNOCK, FM
    GROOME, N
    GANESAN, TS
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 1046 - 1050
  • [4] SURVIVAL AFTER OVARIAN GRANULOSA AND THECA CELL TUMORS
    DEMPSTER, J
    GEIRSSON, RT
    DUNCAN, ID
    [J]. SCOTTISH MEDICAL JOURNAL, 1987, 32 (02) : 38 - 39
  • [5] EVANS AT, 1980, OBSTET GYNECOL, V55, P231
  • [6] FLEMMING P, 1995, AM J SURG PATHOL, V19, P1927
  • [7] FOX H, 1975, CANCER, V35, P231, DOI 10.1002/1097-0142(197501)35:1<231::AID-CNCR2820350128>3.0.CO
  • [8] 2-O
  • [9] DETECTION OF DIMERIC INHIBIN THROUGHOUT THE HUMAN MENSTRUAL-CYCLE BY 2-SITE ENZYME-IMMUNOASSAY
    GROOME, NP
    ILLINGWORTH, PJ
    OBRIEN, M
    COOKE, I
    GANESAN, TS
    BAIRD, DT
    MCNEILLY, AS
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 40 (06) : 717 - 723
  • [10] Hoskins WJ, 1992, PRINCIPLES PRACTICE, P715